- Home
- / TriSalus Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TriSalus Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4
2024-10-29
Market Capitalization
$117.2 M
2024-10-29
Revenue
$45.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 18.5M | 29.4M | 45.2M | ||
| Cost of goods sold | 2.6M | 4.1M | 7.0M | ||
| Gross profit | 15.9M | 25.3M | 38.2M | ||
| Gross profit margin, % | 86.1% | 84.6% | |||
| General and administrative expense | 3.0M | 2.7M | 23.5M | 18.0M | 21.5M |
| Operating expense total | 3.0M | 2.7M | 70.1M | 61.5M | 65.1M |
| EBIT | (3.0M) | (2.7M) | (54.1M) | (36.2M) | (26.9M) |
| EBIT margin, % | -122.9% | -59.7% | |||
| Interest income | 64.0K | 3.0M | 431.0K | 404.0K | 555.0K |
| Interest expense | 16.0K | 1.8M | |||
| Pre tax profit | 6.1M | (59.0M) | (30.0M) | (39.2M) | |
| Income tax expense | 570.9K | 9.0K | 6.0K | 7.0K | |
| Net Income | 4.8M | 5.5M | (59.0M) | (30.0M) | (39.2M) |
| EPS | (6.0) | (1.3) | (1.8) |